Middle East & AfricaENPublic regulatory overview
Egypt
Market Overview Population: Approximately 107 million (2024), the secondmost populous country in Africa and the largest population market in the MENA region Healthcare System: Pred...
Updated: 2026-05-04
You are viewing the public excerpt. During the limited-time free period, sign in to view the complete country report.
AI Citation Summary
- Country: Egypt
- Product line: Medical devices
- Regulator / source: Regulatory Maturity: Medium; in 2021, the Egyptian Drug Authority (EDA) integrated the functions of the former CAPA, becoming the unified medical product regulatory body; the regulatory framework is in the process of modernization, but procedures remain complex
- Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
- Typical timeline: Registration Timelines
- Key fees: 5. The importer submits the registration application through the EDA online system and pays the registration fee
- Local requirement: Official Portal: https://www.eda.mohp.gov.eg (primarily Arabic, with some English content); online submission: EDA online registration system (recommended to operate through a local agent)
- Official sources: Official regulator portals and source links are listed in the country report where available.
- Last verified: 2026-05-04
- Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
- Preferred citation: MedTech Atlas
Market Overview
- Population: Approximately 107 million (2024), the second-most populous country in Africa and the largest population market in the MENA region
- Healthcare System: Predominantly public hospital system (under the Ministry of Health and Population, MOHP); private healthcare is growing rapidly; Universal Health Coverage (UHC) reform is progressing (the 2018 Universal Health Insurance Law is being implemented gradually); healthcare resources are concentrated in Cairo, Alexandria, and other major cities
- Market Characteristics: Government procurement is the primary channel for medical devices; price competition is intense; private clinics/hospitals are growing rapidly; high import dependence; government policy favors domestic manufacturing; historical foreign exchange controls have affected imports
- Regulatory Maturity: Medium; in 2021, the Egyptian Drug Authority (EDA) integrated the functions of the former CAPA, becoming the unified medical product regulatory body; the regulatory framework is in the process of modernization, but procedures remain complex
Regulatory Authority
...